Text Size

Profile of HIV Seropositive Patients (PHSP)

This study has been completed.
Sponsor:
Information provided by:
Universidade Federal de Goias
ClinicalTrials.gov Identifier:
NCT00981279
First received: September 19, 2009
Last updated: October 28, 2009
Last verified: September 2009
History of Changes
  Purpose

The aim of this study was to delineate the epidemiological profile of HIV seropositive patients on antiretroviral therapy at the Clinical Hospital of the Federal University of Goiás.


Condition
HIV Infection
HIV Infections

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Profile of HIV Seropositive Patients on Antiretroviral Therapy at the Clinical Hospital of the Federal University of Goiás

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by Universidade Federal de Goias:

Primary Outcome Measures:
  • Data regarding the personal aspects, aspects related to the infection and information about the most used therapeutic. [ Time Frame: Since the start of the drug therapy ( means of 36 months) ] [ Designated as safety issue: Yes ]

Enrollment: 222
Study Start Date: June 2009
Study Completion Date: September 2009
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
HIV seroposite patients
Seroposite HIV patients that take their treatment at the Clinical Hospital of The Federal University of Goias, and have their records in the hospital.

Detailed Description:

Objective: To delineate the epidemiological profile of HIV seropositive patients on antiretroviral therapy at the Clinical Hospital of the Federal University of Goiás.

Methods: The present study is documental and analitical descriptive and it was conducted at the Clinical Hospital of the Federal University of Goiás, trough data collection of 222 records of individuals in drug therapy. Data were collected regarding the personal aspects, aspects related to the infection and information about the most used therapeutic.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Community sample, with HIV, in drug therapy in the Clinical Hospital of UFG.

Criteria

Inclusion Criteria:

  • All of the patients that had data in the hospital
  • All with the diagnose of HIV
  • Using antiretroviral drugs

Exclusion Criteria:

  • Incompleted records
  • Patients who didn't take their medicines regularly.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00981279

Locations
Brazil
Federal University of Goias
Goiânia, GO, Brazil, 74.605-020
Sponsors and Collaborators
Universidade Federal de Goias
Investigators
Principal Investigator: Caroline N Rodrigues, Graduated UFG
  More Information

Additional Information:
Information about epidemiological datas of HIV patients in Goiás, Brazil  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Caroline Nayanna Rodrigues Santos, Universidade Federal de Goiás
ClinicalTrials.gov Identifier: NCT00981279     History of Changes
Other Study ID Numbers: 129/2009, CONEP- 129/2009
Study First Received: September 19, 2009
Last Updated: October 28, 2009
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Universidade Federal de Goias:
Health Profile
AIDS
Health Promotion
HIV
treatment experienced

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
HIV Seropositivity
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
 Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases

ClinicalTrials.gov processed this record on March 14, 2013